DexCom Gains Pre-Market Traction on Financial Figures, Bullish Views
- July 28th, 2023
- 421 views
DexCom, Inc. (Nasdaq: DXCM) delivered strong results in the second quarter of 2023, with earnings per share (EPS) of $0.34 and revenues of $871.30 million, surpassing the consensus estimate of $0.23 EPS on revenue of $841.62 million.
In response to the robust performance, the company raised its fiscal full-year 2023 revenue guidance to between $3.50 billion to $3.55 billion, up from the previous range of $3.40 billion to $3.52 billion. Analysts had expected revenue of $3.50 billion for the period.
Furthermore, investment firms Baird and Raymond James upheld their positive outlook on DexCom. Baird maintained an Outperform rating and raised the price target from $145 to $153, while Raymond James maintained a Strong Buy rating and increased the price target from $140 to $154.
In pre-market trading, $DXCM surged by $4.95 (+3.83%) to reach $134.31.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login